Skip to main content

High level review of evidence and guidelines to inform the Position Statement on the use of fine needle aspiration (FNA) and core biopsy of the breast in the BreastScreen Australia program

The use of biopsy techniques for the assessment of mammographic screening-detected lesions varies across the BreastScreen Australia program. In this context, there is uncertainty about the appropriate use and limitations of non-excisional biopsy techniques. Accurate biopsy information is essential to the BreastScreen Australia Program, as women with screen-detected lesions and their health professionals make decisions on their management options using this information.

File size:
1.99 MB
Document status:
Greater than 5 years. This resource was developed, reviewed or revised more than 5 years ago and may no longer reflect current evidence or best practice.
Cancer type:
Breast cancer
Publication audience:
Resources for health professionals
Year of publication:
2020